September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Is there any choroidal inflammation in the non-acute stage of Vogt-Koyanagi-Harada disease (VKHD)?
Author Affiliations & Notes
  • Marcelo Mendes Lavezzo
    Ophthalmology, University of São Paulo Medical School, São Paulo, SP, Brazil
  • Viviane Mayumi Sakata
    Ophthalmology, University of São Paulo Medical School, São Paulo, SP, Brazil
  • Ever Ernesto Caso Rodriguez
    Ophthalmology, University of São Paulo Medical School, São Paulo, SP, Brazil
  • Smairah Frutuoso Abdallah
    Ophthalmology, University of São Paulo Medical School, São Paulo, SP, Brazil
  • CELSO MORITA
    Ophthalmology, University of São Paulo Medical School, São Paulo, SP, Brazil
  • Cleide Guimarães Machado
    Ophthalmology, University of São Paulo Medical School, São Paulo, SP, Brazil
  • Mauro Goldbaum
    Ophthalmology, University of São Paulo Medical School, São Paulo, SP, Brazil
  • Sérgio Luís Gianotti Pimentel
    Ophthalmology, University of São Paulo Medical School, São Paulo, SP, Brazil
  • Maria Kiyoko Oyamada
    Ophthalmology, University of São Paulo Medical School, São Paulo, SP, Brazil
  • Carlos Eduardo Hirata
    Ophthalmology, University of São Paulo Medical School, São Paulo, SP, Brazil
  • Joyce H Yamamoto
    Ophthalmology, University of São Paulo Medical School, São Paulo, SP, Brazil
  • Footnotes
    Commercial Relationships   Marcelo Lavezzo, None; Viviane Sakata, None; Ever Rodriguez, None; Smairah Abdallah, None; CELSO MORITA, None; Cleide Machado, None; Mauro Goldbaum, None; Sérgio Pimentel, None; Maria Oyamada, None; Carlos Hirata, None; Joyce Yamamoto, None
  • Footnotes
    Support  FAPESP 2011/50936-7; 2011/19194-4; 2014/01222-0
Investigative Ophthalmology & Visual Science September 2016, Vol.57, No Pagination Specified. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Marcelo Mendes Lavezzo, Viviane Mayumi Sakata, Ever Ernesto Caso Rodriguez, Smairah Frutuoso Abdallah, CELSO MORITA, Cleide Guimarães Machado, Mauro Goldbaum, Sérgio Luís Gianotti Pimentel, Maria Kiyoko Oyamada, Carlos Eduardo Hirata, Joyce H Yamamoto; Is there any choroidal inflammation in the non-acute stage of Vogt-Koyanagi-Harada disease (VKHD)?. Invest. Ophthalmol. Vis. Sci. 201657(12):.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate disease activity in the non-acute stage of VKHD.

Methods : Patients (P) within a minimum 12-mo period from disease onset (defined as non-acute) were prospectively evaluated over at least 1y. Follow-up protocol included every 3-mo clinical and imaging exams [indocyanince green and fluorescein angiographies (FA) and enhanced depth optical coherence tomography]. Full-field (ffERG) and multifocal electroretinograms (mfERG) were carried out at inclusion and at 12-mo follow-up. Imaging exams were read by 3 masked retina specialists. Disease activity signs were defined as clinical signs [anterior chamber cells (ACC), macular edema (ME) and choroidal neovascularization (CNV)] and as subclinical signs [perivascular or optic disc leakage on FA, dark dots and increase in choroidal thickness (CT≥30%)]. Treatment was tailored based on the presence of clinical signs. Patients with no clinical or subclinical signs were designed as pattern A; those with only subclinical signs, as pattern B, and those with both signs, as pattern C.

Results : 20P (17F/3M) with median disease duration of 55mo (12-144mo) were included. While CT increase, ME and CNV had a substantial to optimal reading concordance (kappa>0.8), other angiographic signs had poor concordance (kappa<0.2). During follow-up, cells were observed in 11 evaluations; subclinical posterior segment inflammation (PSI) was simultaneously observed in 64% of eyes. At inclusion, inflammation status was: none in 1P (5%); only subclinical signs in 10P (50%); and both clinical and subclinical in 9P (45%). The follow-up of pattern B patients showed that 2P converted to pattern C (ACC+); ERG parameters became stable in 4P and worsened in 3P (3P not done). Pattern C patients had ERG parameters stable in 2P and worsened in 4p. Treatment was incremented in 13P (65%) during follow-up.

Conclusions : 1. Among PSI signs, those observed on OCT were the most reliable ones; 2. ACC was indicative of subclinical PSI in 2/3 of the patients; 3. 18 out of 25 eyes (72%) included as with no clinical sign of inflammation, had subclinical PSI; during follow-up, only 2 eyes remained with no clinical or subclinical signs of inflammation; 4. Half of the eyes showed retina function deterioration during follow-up, despite remaining with good visual acuity.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

 

Table 1 -Disease activity and electroretinogram parameters of patients with non-acute VKHD at inclusion and at 12-month follow-up.

Table 1 -Disease activity and electroretinogram parameters of patients with non-acute VKHD at inclusion and at 12-month follow-up.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×